Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as paclitaxel and ABI-007, work in different ways
to stop tumor cells from dividing so they stop growing or die. Combining paclitaxel with
ABI-007 may kill more tumor cells.
PURPOSE: Randomized phase I trial to study the effectiveness of combining paclitaxel with
ABI-007 in treating patients who have locally advanced or metastatic solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
National Institutes of Health Clinical Center (CC)